Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Receivables - Other: 2019-2025

Historic Receivables - Other for CureVac N.V (CVAC) over the last 3 years, with Mar 2025 value amounting to $2.2 million.

  • CureVac N.V's Receivables - Other fell 20.19% to $2.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.2 million, marking a year-over-year decrease of 20.19%. This contributed to the annual value of $3.0 million for FY2024, which is 278.12% up from last year.
  • As of Q1 2025, CureVac N.V's Receivables - Other stood at $2.2 million, which was down 25.50% from $3.0 million recorded in Q4 2024.
  • In the past 5 years, CureVac N.V's Receivables - Other ranged from a high of $8.5 million in Q3 2021 and a low of $129,542 during Q3 2023.
  • For the 2-year period, CureVac N.V's Expense - Property Taxes and Insurance averaged around $1.5 million, with its median value being $1.5 million (2021).
  • Data for CureVac N.V's Expense - Property Taxes and Insurance shows a peak YoY increase of 11.75% (in 2022) and a maximum YoY decrease of 31.75% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows CureVac N.V's Receivables - Other stood at $3.1 million in 2021, then fell by 16.08% to $2.6 million in 2022, then plummeted by 69.99% to $781,132 in 2023, then surged by 278.12% to $3.0 million in 2024, then fell by 20.19% to $2.2 million in 2025.
  • Its Receivables - Other stands at $2.2 million for Q1 2025, versus $3.0 million for Q4 2024 and $5.7 million for Q2 2024.